In the GBM, BM size demonstrated the highest predictive power for hemorrhage in BM, followed by age, combination therapy, TKI therapy, radiation therapy, sex, time interval, and EGFR mutation (Table 3). This evidence concerns the gene EGFR and glioblastoma.